特一药业: 关于完成工商变更登记并换发营业执照的公告

Core Viewpoint - The company has successfully completed the registration change and amendment of its articles of association, reflecting an increase in registered capital and a change in the legal representative [1] Group 1: Company Registration Changes - The company held the 33rd meeting of the fifth board and the second extraordinary general meeting of 2025 on June 30 and July 16, 2025, respectively, to approve the proposal for changing the registered capital and amending the articles of association [1] - The registered capital increased from 51,078.8782 million RMB to 51,256.5434 million RMB [1] - The legal representative changed from Xu Danqing to Xu Ronghuang [1] Group 2: Business License Information - The company’s business license has been updated to reflect the new registered capital of 51,256.5434 million RMB [1] - The company is classified as a joint-stock company (listed, natural person investment or control) [1] - The company’s establishment date is May 23, 2002, and its business scope includes pharmaceutical manufacturing, health product production, and medical equipment wholesale [1]